Agoracom: Small Cap Investment - Resverlogix Corp. - Re: Apabetalone treatment reduces SARS-CoV-2 infectivity and completely prevents cardiac damage in a cytokine-storm model

...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Apabetalone treatment reduces SARS-CoV-2 infectivity and completely prevents cardiac damage in a cytokine-storm model

Mar 03, 2021 08:31AM

Re: Apabetalone treatment reduces SARS-CoV-2 infectivity and completely prevents cardiac damage in a cytokine-storm model

narmac

Mar 03, 2021 08:40AM

Re: Apabetalone treatment reduces SARS-CoV-2 infectivity and completely prevents cardiac damage in a cytokine-storm model

jermainejackson

Mar 03, 2021 09:09AM

Re: Apabetalone treatment reduces SARS-CoV-2 infectivity and completely prevents cardiac damage in a cytokine-storm model

Toinv

Mar 03, 2021 10:31AM

Re: Apabetalone treatment reduces SARS-CoV-2 infectivity and completely prevents cardiac damage in a cytokine-storm model

RVXoldtimer

Mar 03, 2021 11:20AM

Re: Apabetalone treatment reduces SARS-CoV-2 infectivity and completely prevents cardiac damage in a cytokine-storm model

10BagR

Mar 03, 2021 11:44AM

Re: Apabetalone treatment reduces SARS-CoV-2 infectivity and completely prevents cardiac damage in a cytokine-storm model

fuzzyjr

Mar 03, 2021 12:34PM

Re: Apabetalone treatment reduces SARS-CoV-2 infectivity and completely prevents cardiac damage in a cytokine-storm model

cityslicker99

Mar 03, 2021 12:37PM

Re: Apabetalone treatment reduces SARS-CoV-2 infectivity and completely prevents cardiac damage in a cytokine-storm model

fuzzyjr

Mar 03, 2021 12:42PM

cityslicker99

Rank: President [?]

Points: 1942 [?]

Votes: 24 Score: 3.8 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Apabetalone treatment reduces SARS-CoV-2 infectivity and completely prevents cardiac damage in a cytokine-storm model

in response to

Re: Apabetalone treatment reduces SARS-CoV-2 infectivity and completely prevents cardiac damage in a cytokine-storm model

fuzzyjr

posted on Mar 03, 2021 05:16PM

Normally several weeks, but under these circumstances I'd imagine the referees might get their reports to the editor inside a couple of weeks.

5 Recommendations

Re: Apabetalone treatment reduces SARS-CoV-2 infectivity and completely prevents cardiac damage in a cytokine-storm model

cityslicker99

Mar 03, 2021 05:16PM

Re: Apabetalone treatment reduces SARS-CoV-2 infectivity and completely prevents cardiac damage in a cytokine-storm model

Texbraska

Mar 03, 2021 06:25PM

Re: Apabetalone treatment reduces SARS-CoV-2 infectivity and completely prevents cardiac damage in a cytokine-storm model

Mazola

Mar 03, 2021 07:37PM

Re: Apabetalone treatment reduces SARS-CoV-2 infectivity and completely prevents cardiac damage in a cytokine-storm model